12/7/20 16:35 | 12/4/20 | CHMA | Chiasma, Inc | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | P | M.d | 26 | 2.60 | 0 | 10 | 104 | 20 | D | | | | | | | | | | | | | | |
12/21/18 14:03 | 12/20/18 | CHMA | Chiasma, Inc | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | DO | P,CEO | P | 24 | 2.50 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
8/20/14 09:36 | 8/19/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | P | 35 | 30.64 | 33 | 1 | 14 | 10 | D | 113 | -65 | -51 | 1 | 5 | -14 | -3 | 3 | 1 | 1 | 11 | -35 | -14 | -41 |
3/5/14 18:46 | 3/4/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | M.d | 44 | 17.64 | 33 | 3 | 43 | 8 | D | 240 | 75 | -34 | -20 | -9 | -14 | -15 | -7 | -7 | -9 | -16 | -41 | -41 | -45 |
2/12/14 16:01 | 2/10/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | M.d | 132 | 17.64 | 33 | 8 | | 6 | D | 290 | 149 | -30 | -6 | -8 | 7 | 10 | 14 | -2 | -5 | -23 | -49 | -54 | -62 |
2/12/14 16:01 | 2/10/14 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | S.d | -470 | 62.61 | 33 | -8 | -56 | 6 | D | 290 | 149 | -30 | -6 | -8 | 7 | 10 | 14 | -2 | -5 | -23 | -49 | -54 | -62 |
11/13/13 17:31 | 11/11/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | M.d | 183 | 17.64 | 33 | 10 | | 6 | D | 458 | 283 | 72 | -12 | -15 | -9 | -2 | 14 | -4 | -20 | -21 | -22 | -61 | -75 |
11/13/13 17:31 | 11/11/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | S.d | -593 | 79.04 | 33 | -8 | -56 | 6 | D | 458 | 283 | 72 | -12 | -15 | -9 | -2 | 14 | -4 | -20 | -21 | -22 | -61 | -75 |
8/28/13 16:30 | 8/26/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | M.d | 44 | 17.64 | 33 | 3 | 500 | 3 | D | 532 | 552 | 190 | 26 | 8 | -3 | -2 | -2 | 2 | 8 | -2 | -21 | -30 | -63 |
8/16/13 16:56 | 8/14/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | M.d | 132 | 17.64 | 33 | 8 | | 1 | D | 526 | 514 | 202 | 41 | 23 | 11 | -5 | -7 | -3 | 0 | -2 | -8 | -30 | -68 |
8/16/13 16:56 | 8/14/13 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | S.d | -701 | 93.44 | 33 | -8 | -94 | 1 | D | 526 | 514 | 202 | 41 | 23 | 11 | -5 | -7 | -3 | 0 | -2 | -8 | -30 | -68 |
3/26/12 09:27 | 3/23/12 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Mark J. | MA | O | CFO | P | 7 | 14.15 | 1 | 1 | New | 1 | D | | -18 | -3 | -15 | -15 | -20 | -12 | -5 | 0 | -1 | -11 | 4 | 6 | 173 |